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Blood culture and stimulation conditions for
the diagnosis of tuberculosis in cervids by the
Cervigam assay
W. R. Waters, M. V. Palmer, T. C. Thacker, K. Orloski, P. Nol, N. P. Harrington,
S. C. Olsen, B. J. Nonnecke
Mitogen- and antigen-induced interferon-γ (IFN-γ) responses of peripheral blood leucocytes from cervids
were evaluated by a commercial whole-blood assay. The assay was applied to Mycobacterium bovis-infected
white-tailed deer and reindeer, M bovis BCG-vaccinated white-tailed deer and elk, and unvaccinated,
uninfected white-tailed deer, fallow deer, elk and reindeer. The responses of the M bovis-infected
white-tailed deer to pokeweed mitogen (PWM) varied with time and between individuals. The responses
of the M bovis-infected reindeer to PWM and M bovis purified protein derivative (PPD) were positively
associated. Samples from tuberculosis-free captive herds in various parts of the USA were also evaluated.
Four per cent of fallow deer, 20 per cent of elk, 44 per cent of white-tailed deer, and 91 per cent of reindeer
had responses to PWM exceeding 0·25 Δ optical density, that is, PWM stimulation minus no stimulation. The
specificity of the responses to M bovis PPD and a Mycobacterium tuberculosis complex-specific antigen
rESAT-6:CFP-10, excluding animals not responding to PWM, ranged from 78 per cent to 100 per cent and was
dependent upon the species and the positive response cut-off value. The results show that the commercial
assay is valid for the detection of TB in reindeer; however, further development of the assay will be required
before it is used in surveillance programmes for white-tailed deer, fallow deer, and elk.
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FARMED deer constitute a significant alternative livestock
industry, with numbers exceeding two million in New
Zealand, one million in China, 500,000 in the USA, 400,000 in
Russia and 100,000 in Canada (Griffin and Mackintosh 2000).
They are exposed to other livestock and to free-ranging wildlife and are moved between herds and across borders, and
there is therefore a risk that infectious diseases may spread
among and between farmed deer, traditional livestock and
free-ranging wildlife. In addition, many deer are kept in parks
reserves and private estates for hunting, zoological, and aesthetic purposes, and their intensive management promotes
the spread of infectious diseases among them.
The causal agent of bovine tuberculosis ( TB ) is
Mycobacterium bovis. This zoonotic pathogen has a wide host
range and is the species of Mycobacterium species most often
isolated from tuberculous cattle and captive deer. There are
several wildlife maintenance hosts of bovine TB, including the
Eurasian badger (Meles meles), brushtail possum (Trichosurus
vulpecula), white-tailed deer (Odocoileus virginianus), bison
(Bison bison), lechwe antelope (Kobus leche) and African
buffalo (Syncerus caffer) (de Lisle and others 2001). In addition to white-tailed deer, M bovis has been isolated from red
deer (Cervus elaphus), sika deer (Cervus nippon), roe deer
(Capreolus capreolus), fallow deer (Dama dama), muntjac
deer (Muntiacus reevesi), mule deer (Odocoileus hemionus),
and several other deer species (Griffin and Mackintosh 2000,
Delahay and others 2001, 2006). Free-ranging and captive deer are implicated in the spread of M bovis to cattle in
the USA, Canada and New Zealand (Essey and Koller 1994,
de Lisle and others 2001, O’Brien and others 2006) and to
human beings (Fanning and Edwards 1991, Whiting and
Tessaro 1994, Wilkins and others 2003, Bucholz 2005). The
prevalence of TB in free-ranging deer populations in southwest England has been estimated to range from 1 per cent for
roe and red deer to 4·4 per cent for fallow deer and 5·2 per
cent for muntjac deer. A recent assessment determined that
free-ranging deer in the UK are a potential source of infection
to cattle in localised areas (Delahay and others 2006).
In the USA, the prevalence of TB in free-ranging white-tailed
deer in certain areas of Michigan reached 5 per cent in the late
1990s, but increased hunting and limitations on wide-scale
feeding practices have decreased this rate to approximately 1

per cent in these areas (O’Brien and others 2006). In western
Spain, there was a steady increase in the prevalence of M bovis
infection in free-ranging Iberian red deer (Cervus elaphus hispanicus) between 1997 and 2002, reaching 1·7 per cent (Parra
and others 2006). M bovis has also been detected in captive
herds of deer in the USA, Canada, New Zealand, Europe and
Asia. In the USA, the spread of bovine TB in captive herds is
strongly associated with inter-herd and cross-country movements of infected deer (Essey and Koller 1994). M bovis was
diagnosed in 41 captive herds of deer in the USA between 1991
and 2003 (Massengill 2005), in 35 captive herds in Canada
between 1989 and 1998 (Essey and Koller 1994, Massengill
2004) and in 41 of 14,842 farmed deer slaughtered in Ireland
between 1993 and 1996 (Quigley and others 1997). TB has
also been diagnosed in captive axis deer (Cervus axis) in India
(Baska and others 1975), in elk (Cervus elaphus nelsoni) in
Korea (Kim and others 2002) and sika deer in Japan (Itoh and
others 1992) and China (Shilang and Shanzhi 1985).
As a result of a series of confirmed cases in the mid 1980s,
TB was designated a ‘notifiable’ disease in farmed deer in Great
Britain (R. de la Rua, personal communication). Similarly, a
1991 outbreak in captive elk, attributed to the importation of
an infected elk, encouraged the government and industry leaders in the USA to draft a Uniform Methods and Rules for the
Eradication of bovine TB in captive cervids (Essey and Koller
1994). In conjunction with the Deer Farmers’ Association
and the Deer Branch of the New Zealand Veterinary Medical
Association, the New Zealand Ministry of Agriculture and
Fisheries adopted a voluntary TB control scheme in 1984 followed by a compulsory national TB control scheme in 1991
(de Lisle and others 2001). Such TB control campaigns have
generally relied on test and removal, slaughterhouse surveillance, movement restrictions and/or wildlife reservoir control strategies. In the UK, USA and Canada, farmed deer are
monitored by a combination of slaughter surveillance and
skin-testing strategies. In the USA the programme is voluntary, but required for interstate transport and herd accreditation. In Canada, a negative TB test for each deer is required for
a change of ownership or any movement, except to slaughter.
In New Zealand, captive deer more than six months of age are
monitored regularly by skin testing (approximately 700,000
were tested in 2004) and all deer are inspected for lesions
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at slaughter (approximately 600,000 were tested in 2004). In
contrast with New Zealand, compliance with TB control strategies in many other countries is poor. In 2003, less than 6 per
cent of approximately 500,000 captive deer in the USA were
tested for TB and less than 1 per cent of 363 captive herds in
the UK submitted to voluntary testing. The reasons for such
poor compliance include inadequate handling facilities, injuries resulting from the handling required, the poor perception by owners of the specificity of skin testing in cervids, and
in the USA, the reduction in interstate movements due to the
restrictions imposed as a result of chronic wasting disease.
Estimates of the sensitivity and specificity of skin tests for
naturally infected red deer, fallow deer and white-tailed deer
vary according to the study and species, with ranges from 80
to 84 per cent for sensitivity and 46 to 86 per cent for specificity (Palmer and others 2001); no estimates are available for
naturally infected reindeer (Rangifer tarandus).
A blood-based TB test for initial surveillance might
increase the compliance of deer farmers. Ancillary bloodbased tests currently used in TB control programmes around
the world include the fluorescence polarisation assay, ELISA
and lateral flow antibody-based tests, in addition to assays
based on interferon-γ (IFN-γ), for example, the Cervigam
assay (Prionics) and lymphocyte blastogenesis. Their use varies between countries and they are not widely utilised with
cervids. The Cervigam assay is particularly attractive owing
to the widespread acceptance of other assays based on IFN-γ,
for example, Bovigam (Prionics) for cattle and Quantiferon
Gold (Cellestis) for human beings.
The aim of this study was to evaluate the Cervigam assay
for TB surveillance by applying it to samples from four species
of captive cervid of significance to the national programme
in the USA. Its objectives were to evaluate a positive standard
as an indicator of the performance of the assay and to determine its specificity with samples from TB-free herds. Antigens
used for the specificity studies include M bovis purified protein derivative (PPD), a complex antigen mixture and a fusion
of recombinant Early Secreted Antigenic Target-6 kDa protein and Culture Filtrate Protein 10 (rESAT-6-CFP-10), generally
a Mycobacterium tuberculosis-complex-specific antigen. Both
antigens are commonly used in TB tests based on IFN-γ.
MATERIALS AND METHODS
Animals, M bovis infection, and
M bovis BCG vaccination
Eleven yearling white-tailed deer were given 300 colony
forming units (cfu) M bovis strain 95-1315 by intratonsillar
instillation as described by Thacker and others (2006) and
Palmer and others (2006), and 13 reindeer were given 1 x
105 cfu of the same strain by the same route. Blood was collected monthly during the six months after the challenge for
evaluation of responses to mitogen and antigen. Infection
was confirmed postmortem in each animal by pathological
examination and bacteriological culture of tissues (Palmer
and others 2006, Thacker and others 2006). All the inoculated
reindeer were classified as reactors to a comparative cervical skin test at 90 and 240 days after inoculation (Palmer
and others 2006); the white-tailed deer were not skin tested.
Despite the different doses administered the distribution and
severity of the lesions were similar in the white-tailed deer
and reindeer.
Eight yearling white-tailed deer and four elk were vaccinated subcutaneously with 5 x 107 cfu M bovis BCG Pasteur
as described by Waters and others (2002, 2004). Blood was
collected six weeks after the vaccination to evaluate the effects
of delays in setting up the assay (to mimic overnight delivery)
on the IFN-γ responses. All the vaccinated white-tailed deer
were classified as reactors to a comparative cervical skin test

TABLE 1: Titration of mitogens for the selection of a positive control stimulant in three elk
and 18 reindeer
Mitogen

Mean (se) optical density
Elk
Reindeer

Concentrations (µg/ml)

Pokeweed mitogen

Concanavalin A

Phytohaemagglutin

Phosphate-buffered saline

20
10
5
20
10
5
20
10
5
1

0·288 (0·02)*
0·275 (0·02)*
0·160 (0·05)
0·103 (0·05)
0·057
0·073
0·085 (0·01)
0·136 (0·03)
0·171 (0·05)

NA

0·059

1·087 (0·18)*
1·041 (0·17)*
0·954 (0·15)*
0·090 (0·01)
0·098 (0·01)
0·097 (0·01)
0·152 (0·03)*
0·226 (0·05)*
0·585 (0·16)*
0·137 (0·01)*
0·081 (0·01)

ND

* Significantly different from phosphate-buffered saline (P<0·05)
NA Not applicable, ND Not determined

four-and-a-half months after they were vaccinated, and all
the elk reacted similarly after eight months.
For the specificity studies, that is the response of uninfected deer to M bovis antigens, samples were collected
from TB-monitored herds with no history of TB. Samples
were obtained from fallow deer in Iowa, North Carolina
and Texas, from elk in Iowa, Minnesota, North Carolina,
Wisconsin and Ontario Canada, from white-tailed deer in
Iowa and Wisconsin, and from reindeer in Alaska, Colorado,
Iowa, Michigan, Nebraska, Ohio, North Dakota, Oregon,
Pennsylvania, Tennessee and Wisconsin. The samples from
Iowa were processed immediately and those from the other
states within 24 hours of collection.
Whole blood cultures and analysis
of IFN-γ production
Heparinised blood was dispensed in 1·5 ml aliquots into
individual wells of a 24-well plate (Falcon 353047; Becton
Dickinson). Treatments included no stimulation (phosphate-buffered saline [PBS] only), and stimulation with 20
µg/ml Mycobacterium avium PPD (PPDa) (Prionics), 20 µg/ml
M bovis PPD (PPDb) (Prionics), 10 µg/ml rESAT-6:CFP-10, or
mitogen (Table 1) in PBS as described by Palmer and others (2004) and Waters and others (2006). Several mitogens,
including phytohaemagglutinin, concanavalin-A and poke
weed mitogen (PWM) were evaluated for use as polyclonal
stimulators of IFN-γ secretion by blood leucocytes from elk
and reindeer (Table 1). The mitogens were not titrated for
the samples from fallow deer owing to the limited volume of
blood available for testing.
As a result of this comparison, PWM at 20 µg/ml was
selected for use in subsequent studies. Diagnostic laboratories in the USA generally consider a PWM response of either
0·1 or 0·25 Δ OD as indicative of a positive IFN-γ response,
that is, with Bovigam and with a limited number of samples
for Cervigam.
In addition to the standard assay procedure, blood tubes
were held for eight or 24 hours before culture to determine

TABLE 2: Relative specificity of the Cervigam assay for animals with positive responses to
pokeweed mitogen (PWM)
PPDb–PPDa and PPDb–PBS

Species*
Elk
White-tailed deer
Reindeer

rESAT-6:CFP-10–PBS

Number

<0·1 (%)

<0·05 (%)

<0·1 (%)

51
95
106

90
98
91

78
92
83

100
97
94

<0·05 (%)
96
95
87·5

* Animals were from TB-monitored herds without any previous history of TB
PPDa Mycobacterium avium purified protein derivative, PPDb Mycobacterium bovis purified protein
derivative
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602
607
729

30
20
10

(b)
40
Δ IFN-γ (ng/ml)

Δ IFN-γ (ng/ml)

(a)
40

0

528
561
563
576

30
20

RESULTS

10
0

0

0

50
100
150
Interval after infection (days)

50
100
150
Interval after infection (days)

Δ IFN-γ (ng/ml)

(c)
FIG 1: Variations in the capacity of blood
40
leucocytes from 11 Mycobacterium
571
601
bovis-infected white-tailed deer to
574
30
respond to pokeweed mitogen (PWM).
604
Blood was collected into heparinised
20
tubes from infected deer at regular
intervals and stimulated with 20
10
µg/ml PWM or phosphate-buffered
saline. After 48 hours incubation at
0
37°C in 5 per cent carbon dioxide in
0
50
100
150
air, interferon-γ (IFN-γ) concentrations
Interval after infection (days)
in plasma were determined by the
Cervigam assay (Prionics). The deer
could be divided into (a) low, (b) moderate and (c) high responders in terms of the
difference between PWM-stimulated and non-stimulated cultures (Δ ng/ml). The numbers
refer to the individual animals

the effects of delays on the response. The blood cultures were
incubated for 48 hours, and plasma was separated by centrifugation and stored at –80°C. The concentrations of IFN-γ in
plasma were determined with an ELISA-based kit (Cervigam;
Prionics). The absorbance of the standards and test samples was read at 450 nm on an ELISA place reader (Molecular
Devices). Individual samples were analysed in duplicate and
the assay was repeated if the duplicate responses were not
consistent. The concentrations of IFN-γ (ng/ml) in the test
samples were determined by comparing the absorbance of
the test samples with the absorbance of the standards within
the linear response of the assay. The data are also presented
as optical density (OD) readings or as differences between the
response to antigen or mitogen and the response to PBS (Δ OD
or Δ IFN-γ [ng/ml]).
The interpretation of the responses to antigen was based
on methods commonly used in the USA for the Bovigam assay,
and a limited number of tests with the Cervigam assay. With
this method, the responses to PPDb must exceed the responses
to both PPDa and PBS by a given cut-off (0·1 or 0·05 Δ OD) to
be considered positive. The responses to the specific antigen
(rESAT-6:CFP-10) were compared with the respective responses
to PBS. The data are presented as the percentage of animals
with responses to PPDb or rESAT-6:CFP-10 up to 0·1 or 0·5 Δ OD
(Table 2).
Statistical analysis
The data were analysed by a one-way analysis of variance followed by a Tukey-Kramer multiple comparisons test, using
a commercially available statistics programme (InStat 2.00;
TABLE 3: Differences between the interferon-γ responses of blood samples from various
cervids stimulated with pokeweed mitogen or not stimulated (that is, phosphate-buffered
saline), expressed as the differences in optical density (OD) determined by ELISA
Species*
Fallow deer
Elk
White-tailed deer
Reindeer

GraphPAD Software). Pearson’s product-moment correlations
were computed between the IFN-γ concentrations in plasma
stimulated with pokeweed mitogen or PPDb.

Number

Mean (se)

Median (range)

213
123
171
116

0·085 (0·02)
0·174 (0·02)
0·426 (0·05)
1·517 (0·08)

0·035 (0–3·637)
0·096 (0–1·354)
0·168 (0–2·862)
1·391 (0·120-3·260)

* Animals were from TB-monitored herds without any previous history of TB
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Δ OD >0·25 (%)
4·2
20·3
43·9
91·4

The magnitude of the responses to PWM was dependent
upon the species of deer (Table 3). Ninety-one per cent of
the reindeer had responses to PWM exceeding 0·25 Δ OD,
whereas less than 44 per cent of the other deer species had
responses to PWM exceeding 0·25 Δ OD. The response by fallow deer was particularly poor with less than 5 per cent having a response to PWM exceeding 0·25 Δ OD. The percentages
of PWM responses exceeding 0·1 Δ OD were 22 per cent, 46
per cent, 56 per cent and 98 per cent for the fallow deer, elk,
white-tailed deer and reindeer, respectively. The mean PWM
responses by the white-tailed deer and reindeer from the TBmonitored herds were similar to those observed by Palmer
and others (2004) and Waters and others (2006) in M bovisinfected and control deer.
The OD readings were standardised to units of ng/ml for
longitudinal studies. The responses of the M bovis-infected
white-tailed deer to PWM varied widely between individual
deer and over time (Fig 1). Some deer had PWM responses
that never exceeded 10 ng/ml (equivalent to approximately
0·2 Δ OD) (Fig 1a) and were categorised as low responders,
but other deer had responses that exceeded 30 ng/ml (equivalent to approximately 0·4 Δ OD) (Fig 1c) and were categorised
as high responders. Over time, the responses of individual
deer to PWM ranged from 0 to 30 ng/ml. Similar variations
in the responses of uninfected white-tailed deer to PWM were
detected (data not shown).
The responses of the M bovis-infected reindeer and
white-tailed deer to PWM and PPDb were positively correlated (P<0·0001) (Fig 2). However, the responses of the
white-tailed deer were not as large, with numerous samples
in the minimal response range, as indicated by the cluster
in the lower left corner of Fig 2a. Thirty-five per cent of the
infected white-tailed deer did not have responses to both
PWM and M bovis PPD exceeding 0·25 Δ OD, indicated by the
shaded box in Fig 2a.
Under field conditions, samples are routinely shipped
overnight, so that there is a delay before they are analysed.
However, delays of eight or 24 hours did not significantly
affect the response to PWM or PPDb of white-tailed deer or
elk vaccinated with M bovis BCG (Fig 3), in agreement with
the results of studies with reindeer (Waters and others 2006).
However, shipping by overnight courier may result in temperature fluctuations, excessive vibrations and atmospheric
pressure changes. Also, caution is needed in the interpretation of these findings owing to limitations in the stimulation
by PWM of samples from elk and white-tailed deer, and their
modest response to vaccination. For white-tailed deer, fallow deer and reindeer, the ability to respond to PWM was not
affected by overnight transport because the responses of samples processed immediately were comparable to those processed after being transported for approximately 24 hours. In
contrast, 86 of the 104 samples from elk (83 per cent) that
were shipped overnight failed to respond to PWM, compared
with 12 of 19 (63 per cent) of those that were processed
immediately.
Samples were obtained from TB-free herds across the USA
and from Canada to evaluate the specificity of the test relative to PPDb and rESAT-6:CFP-10. Animals with PWM responses
less than 0·25 Δ OD were excluded, as well as all the fallow
deer because only 4·2 per cent of them had PWM responses
exceeding 0·25 Δ OD. Table 3 shows that 20·3 per cent of elk,
43·9 per cent of white-tailed deer and 91·4 per cent of reindeer had responses to PWM exceeding 0·25 Δ OD. The inter-
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(a)
3·5
Response to PWM (Δ OD)

pretation of the responses to antigen was based on methods
commonly used in the USA for the Bovigam assay, and the
results of a limited number of tests with the Cervigam assay.
With this method, the responses to PPDb must exceed the
responses to both PPDa and PBS by a given amount, that is
0·1 or 0·05 Δ OD, to be considered positive. The responses
to the specific antigen rESAT-6:CFP-10 were compared to the
responses to PPDb and no stimulation, that is PBS. Specificities
ranged from 78 to 100 per cent depending upon the species
of deer, the antigen, and the cut-off value (Table 2). In general, slightly higher specificities were obtained with rESAT-6:
CFP-10 than with PPDb.

3·0
2·5
2·0
1·5
1·0

r = 0·78, n = 63
y = 1·25x + 0·36
P<0·0001

0·5
0
0

0·5

1·0

DISCUSSION

3·0

3·5

(b)
3·5
Response to PWM (Δ OD)

The initial development of IFN-γ-based tests for TB surveillance
requires a consistent stimulant to demonstrate the functional
capacity of the sample, a determination of specificity with a
reasonable number of viable samples from uninfected animals, and the ability to detect responses to specific antigens
by tuberculous animals. Prior studies have demonstrated the
potential for IFN-γ-based tests to detect tuberculous whitetailed deer, elk and reindeer (Slobbe and others 2000, Palmer
and others 2004, Harrington and others 2006, Waters and
others 2006). For reindeer, these findings were extended: PWM
was identified as a reliable indicator of IFN-γ protein production, few samples were excluded owing to their inability to
produce IFN-γ in response to the positive control stimulant,
and the specificity of the assay was determined to be from
approximately 83 to 94 per cent depending upon the antigen and the cut-off value applied. The specificity of the assay
was at least comparable to the best estimates for the range of
specificities of skin testing of other cervid species, that is, 46
to 86 per cent (Palmer and others 2001). An estimate for the
specificity of skin testing in reindeer is not available, but there
are anecdotal reports of many false positive reactions. These
findings show that the Cervigam assay is potentially useful
for the surveillance.
In contrast, the findings show that the Cervigam assay in
its present form is of limited usefulness with samples from
white-tailed deer, elk and fallow deer. A major concern was
the poor response to mitogen stimulation by more than 50
per cent of the samples from each of these species. With
M bovis-infected white-tailed deer, a poor response to PWM
indicated a concurrent poor response to mycobacterial antigen. Only two of 63 samples from infected white-tailed deer
had a response to PWM of less than 0·25 Δ OD and a concurrent response to M bovis PPD of more than 0·05 Δ OD, the lowest recommended cut-off for a positive response. Only 60 per
cent of the samples from M bovis-infected white-tailed deer
showed a response to PWM exceeding 0·25 Δ OD and these
responses varied widely with time and between individual
deer. These findings indicate either that the sample leucocytes
were unable to produce IFN-γ consistently, or that the assay
was unable to detect the cytokine consistently.
The failure of the tests my be related to the biology of the
host’s response, the interpretation of the assay, the failure of
the assay, and/or the poor quality of the sample. Captive deer
are particularly prone to acute stress when handled, which
may result in sudden increases in the plasma concentration of
cortisol and/or other cytokine response inhibitors (Rehbinder
and others 1982, Kock and others 1987). High levels of cortisol may result in reductions in IFN-γ due to the inhibition
of transcription factor NF-κB. The mechanisms of the regulation of IFN-γ gene expression, including positive and negative
feedback loops of production, are virtually unknown for deer.
Translation of the human IFN-γ gene is inhibited by the activation of a RNA-dependent protein kinase via a pseudoknot
sensor on the 5´-untranslated region of IFN-γ mRNA, and the

1·5
2·0
2·5
Response to PPDb (Δ OD)

3·0
2·5
2·0
1·5
1·0

r = 0·80, n = 75
y = 1·12x + 0·44
P<0·0001

0·5
0
0

0·5

1·0

1·5
2·0
2·5
Response to PPDb (Δ OD)

3·0

3·5

subsequent phosphorylation of eukaryotic initiation factor2α (Kaempfer 2003). Furthermore, T cell activation may be
inadequate owing to the presence of inhibitory cytokines,
other inhibitory factors, or a lack of co-stimulation. Another
reason for the inconsistent detection of IFN-γ in the assay
may be the degradation of synthesised IFN-γ as a result of the
activation of proteases or inhibitors of glycoprotein-processing enzymes (Kosuge and Toyoshima 2000). Alternatively,
changes in the glycosylation of IFN-γ may decrease its halflife. The inhibition of the extracellular release of synthesised
IFN-γ, or the upregulation of IFN-γ receptors with immediate binding of synthesised IFN-γ, or the masking of IFN-γ by
other factors, could also reduce the availability of free IFN-γ
in stimulated plasma.
The mitogens commonly used as positive control stimulants may not consistently induce acceptable quantities of
IFN-γ in samples from captive deer, and the interpretation
of the assay is difficult without a consistent positive control
stimulus. The results of this study emphasise the need for an
adequate cut-off value for the assurance of quality control. A
minimal cut-off value of 0·1 Δ OD, as used in some laboratories in the USA, is probably insufficient to assure the test’s
validity. The unsuccessful stimulation with mitogens may
indicate either that there are different mechanisms of activation in cervids, or that there are inhibiting factors in cervid
blood. The antibodies used for the Cervigam assay may not
recognise IFN-γ from different deer species (as indicated with
fallow deer) and polymorphisms in antigen-binding sites
may result in variability in detection between individual animals (as indicated with white-tailed deer). Delays in setting
up the assay did not significantly affect the response (Fig 3),
but samples from deer may be subject to interference resulting from temperature fluctuations and other transport-associated events, such as excessive vibrations and shaking. In the
elk, a higher proportion of the samples that were shipped
overnight failed to respond to PWM than of the samples that
were processed immediately, indicating that transport may
The Veterinary Record, February 16, 2008

FIG 2: Correlations
between the responses
to pokeweed
mitogen (PWM) and
Mycobacterium
bovis purified protein
derivative (PPDb) of (a)
white-tailed deer and
(b) reindeer, at intervals
after their intratonsillar
inoculation with M
bovis. Heparinised
blood was stimulated
with 20 µg/ml PWM
and M bovis PPD. After
48 hours incubation
at 37°C in 5 per cent
carbon dioxide in air,
interferon-γ
(IFN-γ) concentrations
in plasma were
determined by the
Cervigam assay
(Prionics).
OD Optical density
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FIG 3: Effects of holding
time on the mean (se)
on interferon-γ (IFN-γ)
responses of blood
samples from (a) eight
white-tailed deer and
(b) four elk, which had
been vaccinated with
Mycobacterium bovis
BCG, to stimulation
with pokeweed
mitogen (PWM) or
Mycobacterium
bovis purified protein
derivative (PPDb),
measured with the
Cervigam assay
(Prionics)
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cause interference beyond any caused by delays in setting up
the assay. For the further development of the test it may be
necessary to evaluate additional positive control stimulants,
for example, ionomycin, phorbol-12-myristate 13-acetate
and recombinant interleukin-2, or cocktails of positive control stimulants, to establish IFN-γ protein sequences from different species of deer (at present only the sequence for red
deer has been published) (Sweeney and others 2001), and
investigate different combinations of antibodies for the sandwich ELISA (Buchan and Griffin 1990), and/or enhanced sample delivery/stimulation procedures.
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